Atopic dermatitis is an allergic inflammatory skin disease characterized by the production of the type 2 cytokines in the skin by type 2 innate lymphoid cells (ILC2s) and T helper 2 (T H 2) cells, and tissue eosinophilia. Using two distinct mouse models of atopic dermatitis, we show that expression of retinoid-related orphan receptor  (ROR) in skinresident T regulatory cells (T regs ) is important for restraining allergic skin inflammation. In both models, targeted deletion of ROR in mouse T regs led to exaggerated eosinophilia driven by interleukin-5 (IL-5) production by ILC2s and T H 2 cells. Expression of ROR in skin-resident T regs suppressed IL-4 expression and enhanced expression of death receptor 3 (DR3), which is the receptor for tumor necrosis factor (TNF) family cytokine, TNF ligand-related molecule 1 (TL1A), which promotes T reg functions. DR3 is expressed on both ILC2s and skin-resident T regs . Upon deletion of ROR in skin-resident T regs , we found that T regs were no longer able to sequester TL1A, resulting in enhanced ILC2 activation. We also documented higher expression of ROR in skin-resident T regs than in peripheral blood circulating T regs in humans, suggesting that ROR and the TL1A-DR3 circuit could be therapeutically targeted in atopic dermatitis.
INTRODUCTION
Atopic dermatitis (AD) is the most common skin inflammatory disease affecting ~17% of children in developed nations (1) . AD lesions are characterized by the presence of activated T helper 2 (T H 2) cells, as well as by the expansion of type 2 innate lymphoid cells (ILC2s) (2) (3) (4) . Both T H 2 cells and ILC2s may contribute to allergic skin inflammation in AD. Cutaneous inflammation elicited by topical application of calcipotriol (MC903), a low-calcemic analog of vitamin D, has been used as a mouse model of acute AD (5, 6) . Allergic inflammation in this model is accompanied by expansion of ILC2s driven by epithelial cytokines (2, 4) . More importantly, it is dependent on ILC2s; it is preserved in Rag1 −/− mice and is severely attenuated in Tslpr −/− mice, ILCdepleted Rag1 −/− mice, and ILC2-deficient Rora sg/sg /wild-type (WT) bone marrow chimeras (2, 4) . Cutaneous inflammation elicited by repeated epicutaneous (EC) application of ovalbumin (OVA) or peanut extract to tape-stripped mouse skin provides an antigen-driven mouse model of acute AD (7) (8) (9) . Allergic inflammation in this model is dependent on T cells, because it is abolished in Rag2 −/− mice (9, 10) . CD4 +
FOXP3
+ T regulatory cells (T regs ) constitute a substantial subset of immune cells residing in murine and human skin (11) . Lack of T regs in humans and mice results in immune dysregulation associated with allergic skin inflammation (12, 13) . T reg numbers are unaltered in AD skin lesions (14) . Thus, the role of skin-resident T regs in controlling allergic skin inflammation is unclear. Here, we have dissected the molecular architecture of skin-resident T regs and identified retinoid-related orphan receptor  (ROR) as a regulator of genes in T regs responsible for suppressing allergic skin inflammation.
RESULTS
Skin-resident T regs exhibit an activated signature and express the transcription factor ROR Specialization of tissue-resident T regs is an important factor in maintaining tissue homeostasis and modulating local immune responses. To investigate whether skin-resident T regs exhibit a specialized phenotype, we compared the phenotype of skin-resident T regs and T regs in skin-draining lymph node (dLN). About 45% of CD4 + T cells in ear skin expressed FOXP3 compared with ~20% of CD4 + T cells in dLNs (Fig. 1A) . Skin T regs localized around dermal blood vessels and interfollicular areas (fig. S1A). We compared the transcriptome of CD3 + CD4 + YFP + T regs from the skin and dLN of Foxp3 eyfp-cre mice. Skin T regs differed from dLN T regs by more than 5000 genes [fold change > 2; false discovery rate (FDR) < 0.05]. Skin T regs were enriched for the expression of genes encoding signaling receptors [Icos and Il1rl1 (ST2)], activation markers (Cd44 and Klrg1), effector molecules (Il10, Ctla4, and Areg), and tissue-homing receptors (Ccr3, Ccr8, and Ccr10) (Fig. 1B) . Flow cytometry demonstrated that the percentage of T cells that expressed ST2, ICOS, and CD44 and the expression levels of these markers were significantly higher in skin T regs than in dLN T regs (Fig. 1C) . Rora, the gene encoding the transcriptional regulator ROR, was highly up-regulated in skin T regs (Fig. 1B) . This was confirmed by quantitative polymerase chain reaction (qPCR) (Fig. 1D) . RORA expression was significantly higher in CD4   +   CD25   +   CD127 lo skin T regs than in circulating T regs in humans (Fig. 1E) . Human skin T regs , similar to mouse skin T regs , display an activated signature with increased expression of ICOS, CTLA4, and CD44 (15) .
To examine and map the fate of ROR-expressing T regs , we bred Rora cre mice to Rosa26Yfp (R26Y) mice. In Rora cre R26Y mice, yellow fluorescent protein (YFP) marks cells that are expressing or previously expressed Rora. Most of the skin T regs (>90%) in Rora cre R26Y mice expressed YFP compared with a small fraction (~5%) of T regs from dLNs ( the floxed fourth exon of Rora in these mice ( fig. S4A ). The numbers of YFP + T regs were not altered in the skin or dLNs of these mice ( fig. S4B ), indicating that ROR is not required for the accumulation or maintenance of T regs in the skin. The cytokine interleukin-10 (IL-10) is important for T reg function in the gut and lungs (19 (Fig. 3A) . IL-5 plays a critical role in tissue eosinophilia by synergizing with eotaxins and promoting eosinophil survival in tissues (21, 22) . IL-5 levels were significantly higher in MC903-treated skin of 
Rora
fl/fl mice compared with controls (Fig. 3D ). The chemokine CCL8 is up-regulated in AD skin lesions (24) and is critical for the recruitment of CCR8-expressing IL-5 + T H 2 cells to the skin in a mouse model of AD (24) . Ccl8 expression was strongly increased in MC903-treated skin of 
fl/fl mice, which could underlie the increased influx of myeloid cells in these mice (Fig. 2F ).
ROR deficiency in T regs alters the expression of genes involved in T reg cell migration and function and skews T regs to IL-4-producing effectors
To gain an understanding of how ROR regulates the function of skin T regs , we performed next-generation sequencing (NGS) transcriptomic analysis on T regs isolated from untreated and MC903-treated skin of T reg suppressive activity is mediated in part by the nucleotides adenosine and cyclic adenosine 3′,5′-monophosphate (cAMP) (28) . T regs from untreated and MC903-treated skin showed strongly decreased expression of Nt5e, which encodes the 5′ ectonucleotidase CD73 that metabolizes AMP to adenosine (28) , and reduced surface expression of CD73 compared with controls (Fig. 4, B and D) , whereas expression of Pde3b, which encodes the phosphodiesterase 3B that breaks down cAMP (29) , was increased (Fig. 4B) . Expression of Gzmb, which encodes granzyme B that mediates T reg cytotoxic activity, was up-regulated ( Fig. 4B) , indicating that not all genes involved in T reg function were down-regulated in the absence of ROR.
Expression of IL-4 in T regs inhibits their ability to suppress T H 2 cells and ILC2s (30, 31) . Il4 levels were elevated in skin T regs from Foxp3 eyfp-cre Rora fl/fl mice compared with controls (Fig. 4, A and B ).
This was confirmed by qPCR (Fig. 4E) . Furthermore, the percentage of CD4 factor RUNX1 inhibits Il4 expression in T regs (32 (Fig. 5C ). The DR3 ligand TL1A is released by endothelial and myeloid cells. TL1A synergizes with the epithelial cytokines IL-33, IL-7, and IL-25 to enhance IL-5 expression in human and murine ILC2s and to promote allergic inflammation (33, 35, 36) . TL1A also acts on T regs to increase their proliferation and their ability to suppress allergic airway inflammation (34) . Skin TL1A levels were not altered after MC903 treatment and were comparable in (Fig. 5D ). Given this finding, we tested the hypothesis that selective down-regulation of the TL1A receptor DR3 on T regs from skin of 
Rora
fl/fl mice. This was evidenced by a significant decrease in dermal thickness, infiltration by CD45 + cells and eosinophils, and expression of Il5 and Ccl8 compared with isotype control antibody-treated mice (Fig. 6, G to J) . These results suggest that ROR expression in T regs restrains TL1A-mediated allergic skin inflammation and eosinophilia elicited by cutaneous application of MC903.
ROR deficiency in T regs results in exaggerated skin inflammation in response to EC sensitization
To investigate whether ROR deficiency in T regs plays a role in restraining antigen-driven T cell-dependent allergic skin inflammation, we subjected Foxp3 (Fig. 6, B to D) . Furthermore, the numbers of all cell populations analyzed, including eosinophils, basophils, neutrophils, mast cells, CD4 Columns and bars represent means and SEM. *P < 0.05, ***P < 0.001. ns, not significant.
of 12
Min.
Max.
Circadian rhythm-Nr1d1, Nr1d2
Chemokine-Ccl12, Ccl24
NF-κB signaling-Irak4, Tirap
Chemokine receptor-Ccr3, Ccr5 we have identified ROR as a regulator of T reg genes responsible for suppressing allergic skin inflammation. The vast majority of mouse skin T regs expressed ROR and had an activated phenotype. In contrast, a small minority of T regs in skin dLNs expressed ROR and had an activated phenotype. It remains to be determined whether circulating ROR + T regs are specifically attracted to the skin or whether the skin environment drives ROR expression in T regs . The numbers of skin T regs are not altered in Foxp3 eyfp-cre Rora fl/fl mice. Furthermore, although the majority of human blood T regs express the skin-homing receptor CLA (37) , human blood T regs expressed fivefold less RORA mRNA compared with skin T regs . These findings argue for local acquisition of ROR expression by T regs in the skin.
We demonstrated that ROR expression in T regs restrains allergic skin inflammation induced by topical application of MC903, an AD model dependent on ILC2s (2, 4) . This was evidenced by increased ear swelling and dermal thickness in 
Rora
fl/fl mice we used. ROR was essential for repressing IL-5 expression in fastresponding ILC2s and for restricting the CCL8-dependent recruitment of IL-5 + T H 2 effector cells to the skin, likely by dampening the expression of Ccl8 in the skin, and particularly in skin T regs . ROR also repressed IL-13 and IL-4 expression by skin ILCs, although the effect did not reach statistical significance, but had no effect on IL-4 and IL-13 expression by T cells. We propose that in addition to their role in restraining adaptive immunity, a central function of T regs resident in barrier interfaces, such as skin, is to inhibit the rapid activation of innate lymphocytes. The unrestrained activation of these innate sentinels may contribute to acute flare-ups in allergic diseases.
ROR regulated the expression of several genes important for T reg migration and function. Changes in chemokine receptor expression may underlie the increased motility of T regs in 
fl/fl mice may be a direct effect of decreased TL1A activation of T regs and/or increased availability of TL1A to activate ILC2s. Definitive evidence of the role of DR3 expression on T regs in limiting allergic skin inflammation and its mechanism of action awaits the generation and study of mice with selective deficiency of Tnfrsf25 in T regs and/or ILC2s. Furthermore, our data indicate that ROR restrains the conversion of T regs into IL-4-producing effector cells, possibly because ROR drives the expression of Runx1, which inhibits Il4 gene transcription. Derepression of the T H 2 proinflammatory genes in ROR-deficient skin T regs likely contributes to the enhanced allergic skin response in Foxp3 eyfp-cre Rora fl/fl mice. Furthermore, IL-10 expression was increased in ROR-deficient skin T regs . The transcription factor AhR (aryl hydrocarbon receptor) enhances IL-10 production in T regs (39) , whereas IL-4 suppresses it (40) . We observed increased Ahr and Il4 expression in ROR-deficient skin T regs . Increased expression of AhR and IL-4 may underlie the enhanced IL-10 expression by these cells.
In addition to its role in suppressing ILC2-dependent allergic skin inflammation driven by topical application of MC903, ROR expression in T regs was important for suppressing T cell-dependent allergic skin inflammation driven by topical application of the antigen OVA to tape-stripped skin, a T cell-dependent mouse model of AD. This was evidenced by increased epidermal thickness, increased dermal infiltration by CD45 + inflammatory cells (including eosinophils, mast cells, neutrophils, T cells, and ILC2s), increased cutaneous expression of Il4, and increased expression of IL-5 by T cells and ILCs.
We demonstrate significantly higher expression of RORA in human skin T regs than in blood T regs , suggesting that our results may be applicable to humans. Our results may be particularly relevant to patients with AD, a disease in which both T H 2 cells and ILC2s play important roles in allergic skin inflammation. RORA polymorphisms in asthma (41) and Rora down-regulation in dogs with AD (42) further suggest that ROR may play a regulatory role in atopic diseases. Moreover, expression of Rora in T regs resident in tissues such as the gut (43) may endow them with the ability to dampen allergic inflammation in organs other than skin.
MATERIALS AND METHODS

Mice
Foxp3
eyfp-cre (C57BL/6), R26R (C57BL/6), Rag1 −/− (C57BL/6), and Rorc gfp (C57BL/6) mice were purchased from the Jackson Laboratory (Bar Harbor, ME). Rora fl/fl (C57BL/6) mice were generated in the laboratory of P. Chambon (France) (44) . Rora cre (C57BL/6) mice were generated in the laboratory of D. O'Leary (45) . Tnfrsf25 −/− mice were generated by E. Y. Wang and obtained from the laboratory of R. Siegel.
egfp reporter mice were a gift from T. Chatila. All mice were kept in a pathogen-free environment. All procedures performed on the mice were in accordance with the Animal Care and Use Committee of the Children's Hospital Boston.
Preparation of skin cell homogenates from mice and human skin Dorsal and ventral ear murine skin was separated using tweezers, chopped, and digested in complete Dulbecco's modified Eagle's medium containing Liberase TL (2.5 mg/ml, Roche, Life Technologies) and deoxyribonuclease (DNase) I (20 ng/ml, Sigma) for 90 min at 37°C, with vigorous shaking. Digested tissue was mechanically disrupted with a plunger, filtered, washed, and suspended in media for flow cytometric analysis. Human skin surgical discards of facial skin were obtained from the laboratory of R. Clark (Brigham and Women's Hospital). To obtain cells from human skin, we removed all the fat using a scalpel and chopped the skin into small pieces and digested for 2 hours at 37°C with vigorous shaking in complete RPMI containing collagenase IV (2 ng/ml, Worthington Pharmaceuticals), hyaluronidase (2 ng/ml, Sigma), and DNase I. Digested tissue was mechanically disrupted using a plunger, filtered, centrifuged, and resuspended for cell sorting.
Flow cytometry
All antibodies were obtained from eBioscience and BioLegend, except anti-mouse Siglec-F, which was purchased from BD Biosciences. Cells were preincubated with Fc receptor-specific blocking monoclonal antibody (2.4G2) and washed before staining. Staining with CD45 and fixable viability dye (eBioscience) was used for FACS analysis of skin cell homogenates. One hundred twenty-three count beads from eBioscience were used for estimating cell counts. Cells were analyzed on LSRFortessa (BD Biosciences), and the data were analyzed with FlowJo software (v9.7).
Intracellular staining analysis for cytokines and transcription factors LN and skin cell suspensions were incubated with media containing phorbol 12,13-dibutyrate, ionomycin, GolgiPlug, and GolgiStop for 3 hours. Staining for surface markers was performed, followed by fixation and permeabilization using BD Cytofix/Cytoperm buffer. Cells were incubated with antibodies against cytokines, IL-4, IL-5, and IL-13, along with antibodies to FOXP3, overnight in Perm/Wash buffer (BD Biosciences). This protocol was also used to stain cells with anti-FOXP3 and anti-HELIOS markers without quenching the emission of YFP in Rora cre R26R mice.
MC903 treatment
MC903 (catalog no. 2700) was purchased from Tocris Biochemicals.
The stock was reconstituted in ethanol. MC903 (2 nM) (in a volume of 20 ml) was topically applied on the ears of mice every other day, for a total of four applications. Ethanol (vehicle) was applied on the control ear. Mice were sacrificed 1 day after the last application.
RNA preparation and qPCR
Cells were sorted directly into the lysis buffer of RNA Isolation Micro kit (Zymo Research), and RNA was prepared on the basis of kit instructions. For analysis of transcripts in skin, skin tissue was stored in RNAlater (Ambion) and homogenized using a tissue homogenizer, and RNA was prepared using RNA isolation kits (Zymo Research).
Reverse transcription was performed with an iScript cDNA synthesis kit (Bio-Rad Laboratories). PCRs were run on an ABI Prism 7300 (Applied Biosystems) sequence detection system platform. TaqMan primers and probes were obtained from Life Technologies. The housekeeping gene  2 -microglobulin was used as a control. Relative mRNA expression was quantified using the 2 −Ct method.
RNA-seq and transcriptomic analysis CD3
T regs from skin and dLNs were sorted on Aria cell sorter into the lysis buffer (PicoPure RNA Isolation kit, Life Technologies). RNA was prepared after DNase treatment (Qiagen) and sent to Dana-Farber Cancer Institute Molecular Biology Core Facility for library preparation and sequencing. Replicates with a minimum RIN (RNA integrity number) score of 7 were processed. Complementary DNA (cDNA) was synthesized using Clontech SMART-Seq v4 reagents from 500 pg of RNA and fragmented to a mean size of 150 base pairs (bp) with a Covaris M220 ultrasonicator. Illumina libraries were prepared from cDNA using Rubicon Genomics ThruPLEX DNA-seq reagents according to the manufacturer's protocol. The finished doublestranded DNA libraries were quantified and sequenced on a single Illumina NextSeq 500 sequencing system run with single-end 75-bp reads by the Dana-Farber Cancer Institute Molecular Biology Core Facility. TopHat was used to align reads to mouse genome [Mm9, National Center for Biotechnology Information (NCBI)], and HTSeq was used to estimate read counts. Read counts from all experiments are listed in table S1. Highly correlated triplicate samples were used for comparative analysis (fig. S6 ). DEseq2 was used to normalize data and access differential gene expression with an FDR of <0.05. Expression levels for individual genes are represented as reads per kilobase of transcript per million mapped reads (RPKM). Heat maps were generated using GENE-E software (Broad Institute). RNA-seq raw data can be accessed through accession no. GSE99086.
Intravital two-photon imaging
Foxp3
egfp (Balb/c) mice were anesthetized intraperitoneally using ketamine (100 mg/kg) and xylazine (10 mg/kg). One of the ears was gently attached to an aluminum block using double-sided tape. Ear temperature was maintained at 33°C using a heating pad. GenTeal (Novartis) eye gel was spread over the ear to allow immersion of the 20× objective (0.95 numerical aperture). Images were acquired using an upright microscope (Prairie Technologies) coupled to a Mai Tai Ti:Sapphire laser (Spectra-Physics). To visualize vasculature, mice were intravenously injected with Qdot655 (Molecular Probes) diluted in phosphate-buffered saline. Images were acquired with a laser wavelength of 900 nm for optimal GFP excitation and secondharmonic generation. Epidermis and dermis were analyzed by acquisition of ~100-mm optical stacks every 30 to 60 s for 15 to 60 min with 4-mm spacing. Images were transformed into four-dimensional timelapse movies and analyzed using Imaris software versions 7.4.2 and 8.4.1 (Bitplane). Imaging experiments were performed in the Balb/c background, but similar results were observed using Foxp3 egfp (C57BL/6) mice. Balb/c mice were preferred to avoid autofluorescence from melanin.
Histology
Tissue samples were stored in 10% formalin and sent to the histology core at Boston Children's Hospital for processing and hematoxylin and eosin (H&E) staining. Slides were analyzed on the 20× objective of bright-field microscope (Nikon), and captured images were analyzed using ImageJ software for enumeration of dermal thickness.
Local treatments by intradermal injection
Recombinant TL1A (0.9 g/l; catalog no. 753008, BioLegend) was injected intradermally into the ear of mice in a total volume of 10 ml every day for 3 days. Isotype antibody or anti-human/mouse TL1A antibody (R&D Systems) was injected intradermally into the ears in a total volume of 10 l every other day for 3 days. Cells from ears were prepared, and flow cytometric analysis was performed as described earlier.
Epicutaneous sensitization
Six-to 8-week-old female mice were epicutaneously sensitized for 2 weeks, as described previously (9) . In brief, for each treatment, female mice were anesthetized, and then their back skin was shaved and tape-stripped with a film dressing (Tegaderm, 3M). EC sensitization consisted of applying a 1-cm 2 gauze containing 200 g of OVA (SigmaAldrich) to the skin after each tape stripping and securing it with a film dressing. Analyses were done at day 12.
Enzyme-linked immunosorbent assays
For detection of total IgE levels, mouse sera were prepared and enzymelinked immunosorbent assay (ELISA) was performed (88-50460-88, eBioscience) as per the manufacturer's instructions. For quantification of cytokines in the tissue, mouse ears were flash-frozen in liquid nitrogen. Tissue was chopped, lysed, and homogenized in 500 ml of T-PER tissue protein extraction buffer (catalog no. 78510, Thermo Fisher Scientific) in the presence of complete protease inhibitor and phosphatase inhibitors. Total protein was quantified using a bicinchoninic acid protein assay kit (catalog no. 23227, Pierce), and levels of IL-5 were enumerated after normalizing to the total protein content in the tissue. IL-5 levels in ear skin were measured using Quantikine IL-5 kit (M5000, R&D Systems), and TL1A levels were measured using DuoSet ELISA kit (DY1896-05, R&D Systems).
Statistical analysis
Statistical significance was determined by the Mann-Whitney test or analysis of variance (ANOVA) analysis using GraphPad Prism. P < 0.05 was considered statistically significant. Table S1 . Summary of RNA-seq experiments. Movie S1. Intravital two-photon imaging of the untreated ear dermis of a Foxp3 egfp animal.
SUPPLEMENTARY MATERIALS
Movie S2. Intravital two-photon imaging of the MC903-treated ear dermis of Foxp3 egfp mice.
